TNBC is found in about 15 out of every 100 cases and is more likely to occur in Hispanics and African-Americans, research shows.

"Targeted treatment options for TNBC are limited," said Sachdeva, adding that current treatments, such as infusions, tend to result in poor patient compliance and increased toxicity. "We are confident that the compounds we are currently working with are an effective treatment for triple-negative breast cancer," Sachdeva said.

BET Health News - We go beyond the music and entertainment world to bring you important medical information and health-related tips of special relevance to Blacks in the U.S. and around the world. Click here to subscribe to our newsletter.